This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Keratoconus or Corneal Ectasia
and you are
between 18 and 30
years old
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

Compare different corneal parameters and visual outcome of corneal collagen cross-linking (CXL) with conventional versus accelerated ultraviolet-A irradiation using riboflavin with hydroxypropyl methylcellulose.

Provided treatments

  • Device: UV-X 1000 (3 mW/cm²)
  • Procedure: UV-X 2000 (9 mW/cm²)
  • Drug: riboflavin with hydroxypropyl methylcellulose

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02883478. The sponsor of the trial is Oslo University Hospital and it is looking for 40 volunteers for the current phase.
Official trial title:
A Randomized Study of Clinical and Structural Outcome of Corneal Collagen Crosslinking (CXL) With Conventional Versus Accelerated Ultraviolet-A Irradiation Using Riboflavin With Hydroxypropyl Methylcellulose (HPMC).